Options for treating carbapenem-resistant Enterobacteriaceae.
about
Antibiotic regimens for treatment of infections due to multidrug-resistant Gram-negative pathogens: An evidence-based literature reviewNew Delhi Metallo-β-Lactamase 1(NDM-1), the Dominant Carbapenemase Detected in Carbapenem-Resistant Enterobacter cloacae from Henan Province, ChinaIn vitro Pharmacokinetics/Pharmacodynamics Evaluation of Fosfomycin Combined with Amikacin or Colistin against KPC2-Producing Klebsiella pneumoniae.Emergence of Extensively Drug-Resistant Proteus mirabilis Harboring a Conjugative NDM-1 Plasmid and a Novel Salmonella Genomic Island 1 Variant, SGI1-ZOccurrence of Diverse Antimicrobial Resistance Determinants in Genetically Unrelated Biocide Tolerant Klebsiella pneumoniae.Treatment options for infections caused by carbapenem-resistant Enterobacteriaceae: can we apply "precision medicine" to antimicrobial chemotherapy?Tigecycline-Amikacin Combination Effectively Suppresses the Selection of Resistance in Clinical Isolates of KPC-Producing Klebsiella pneumoniae.Basis for selecting optimum antibiotic regimens for secondary peritonitis.Colistin Resistance Caused by Inactivation of the MgrB Regulator Is Not Associated with Decreased Virulence of Sequence Type 258 KPC Carbapenemase-Producing Klebsiella pneumoniae.Antibiotic Distribution into Cerebrospinal Fluid: Can Dosing Safely Account for Drug and Disease Factors in the Treatment of Ventriculostomy-Associated Infections?In Vitro Activity of Aztreonam-Avibactam against Enterobacteriaceae and Pseudomonas aeruginosa Isolated by Clinical Laboratories in 40 Countries from 2012 to 2015.Using carbapenems for carbapenem-resistant Klebsiella pneumoniae-Are we flogging a dead (work)horse antibiotic?Emergence of pan-resistance in KPC-2 carbapenemase-producing Klebsiella pneumoniae in Crete, Greece: a close call.Editorial Commentary: Fosfomycin: The Current Status of the Drug.In vitro activity of aztreonam-avibactam against a global collection of Gram-negative pathogens from 2012 and 2013.The pros, cons, and unknowns of search and destroy for carbapenem-resistant enterobacteriaceae.In Vitro Activity of Neomycin, Streptomycin, Paromomycin and Apramycin against Carbapenem-Resistant Enterobacteriaceae Clinical Strains.Activity of Ceftolozane-Tazobactam against Carbapenem-Resistant, Non-Carbapenemase-Producing Pseudomonas aeruginosa and Associated Resistance Mechanisms.Screening for synergistic activity of antimicrobial combinations against carbapenem-resistant Enterobacteriaceae using inkjet printer-based technology.Burden and Management of Multidrug-Resistant Organisms in Palliative Care.In vitro antibacterial effect of fosfomycin combination therapy against colistin-resistant Klebsiella pneumoniae.
P2860
Q26796605-8B847BDD-E710-4826-9655-83944F223E20Q28547165-A0702C22-2CD7-4C0E-BA11-4FF696520BF1Q33804813-306F013D-3E09-43A5-9B39-FFF715CAC042Q36075915-725505AB-0D9A-4A97-9573-D590FB50E562Q36199746-A7033761-FAF3-410A-9F2B-783E85F8F232Q37146405-3506CC54-E415-4AB7-A13D-99915A86BE30Q37188061-982C2F0C-B2DC-4219-989B-3FAAC9C94A7EQ38633450-21D67DA7-9F31-4F8B-A336-B08BC475B953Q39514967-DCA77A6A-39B1-424E-BD7C-55D5E5D49AD7Q40047150-AA3EB7CF-88B2-42E8-8FC9-F9A57D7454D4Q40166206-9B8BB455-76FB-4324-9161-6AD4443316F1Q40552307-61B47F50-C7AE-4167-9401-D174185AE896Q40815715-FB1C90C4-806C-4DCF-BCA7-E16CBE7EC074Q41169961-0BA1BCB8-5B43-4C94-AF35-2912A971B322Q41240109-2F83C369-4641-4BBC-92DC-631D5457CAD3Q41282042-0E8780F6-F647-40A0-878B-2FEBC43536DCQ47102404-CF7EEC53-CF3F-44F2-96CC-B3C796A3BAC5Q47218700-6BA9CDC4-2542-4778-8091-EAB9C156B5E3Q47677580-9786B624-E08C-412F-8CAE-8D7B1D6A954CQ49444973-BA248053-8A79-4A07-BC21-826A13C72813Q55071894-45994E2C-A6D1-4E91-8F02-6461FB3108C8
P2860
Options for treating carbapenem-resistant Enterobacteriaceae.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Options for treating carbapenem-resistant Enterobacteriaceae.
@en
type
label
Options for treating carbapenem-resistant Enterobacteriaceae.
@en
prefLabel
Options for treating carbapenem-resistant Enterobacteriaceae.
@en
P1476
Options for treating carbapenem-resistant Enterobacteriaceae.
@en
P304
P356
10.1097/QCO.0000000000000109
P577
2014-12-01T00:00:00Z